Epizyme (EPZM) Announces Earning $6M Milestone Related to GSK3326595 Phase 1
Tweet Send to a Friend
Epizyme, Inc. (Nasdaq: EPZM) announced it has earned a $6 million milestone payment from GlaxoSmithKline (NYSE: GSK). The milestone payment ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
